Levetiracetam as add-on Treatment of Myoclonic Jerks in Adolescents + Adults

Clinical trial NCT00150774 · COMPLETED

Trial details

NCT number: NCT00150774
Sponsor: UCB Pharma
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Generalized Convulsive Epilepsy

Start date: 2001-11-01
Primary completion: 2004-12-01
Enrollment: 116

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.